Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer. - Wikidata - wikimedia - TriplyDB

Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer.

Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer.

http://www.wikidata.org/entity/Q34957004

about

Circulating long non-coding RNAs in cancer: current status and future perspectives Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics The Association between Abnormal Long Noncoding RNA MALAT-1 Expression and Cancer Lymph Node Metastasis: A Meta-Analysis Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism Long Non-coding RNAs in Urologic Malignancies: Functional Roles and Clinical Translation Long Noncoding RNAs as Biomarkers in Cancer.Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression.Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma.RNA biomarkers to facilitate the identification of aggressive prostate cancer LncRNAs: From Basic Research to Medical Application LncRNA ontology: inferring lncRNA functions based on chromatin states and expression patterns.Identification of specific DNA methylation sites on the Y-chromosome as biomarker in prostate cancer.LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer.Long noncoding RNA DANCR promotes invasion of prostate cancer through epigenetically silencing expression of TIMP2/3 Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?Long noncoding RNAs and neuroblastoma.Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.MiR-204/ZEB2 axis functions as key mediator for MALAT1-induced epithelial-mesenchymal transition in breast cancer.The Non-Coding Transcriptome of Prostate Cancer: Implications for Clinical Practice.Circulating long noncoding RNAs as novel biomarkers of human diseases.CCAT1: an oncogenic long noncoding RNA in human cancers.LncRNAs as an intermediate in HPV16 promoting myeloid-derived suppressor cell recruitment of head and neck squamous cell carcinoma.Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets.Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer Liquid biopsy: a step forward towards precision medicine in urologic malignancies.MicroRNAs, Long Noncoding RNAs, and Their Functions in Human Disease.Multiple functions of long non-coding RNAs in oxidative stress, DNA damage response and cancer progression.Urinary Biomarker Panel to Improve Accuracy in Predicting Prostate Biopsy Result in Chinese Men with PSA 4-10 ng/mL.Metastasis-associated lung adenocarcinoma transcript 1 promotes the proliferation of chondrosarcoma cell via activating Notch-1 signaling pathway.Long noncoding RNA linc00617 exhibits oncogenic activity in breast cancer.Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma.lincRNA-p21 inhibits hepatic stellate cell activation and liver fibrogenesis via p21.Long Noncoding RNAs as Diagnostic and Therapeutic Targets in Type 2 Diabetes and Related Complications.Specific long non-coding RNAs response to occupational PAHs exposure in coke oven workers.Long non-coding RNAs: new frontiers for advancing personalized cancer medicine in prostate cancer.Upregulation of long noncoding RNA LOC440040 promotes tumor progression and predicts poor prognosis in patients with prostate cancer.Long non-coding RNAs and prostate cancer.The long noncoding RNA Malat1: Its physiological and pathophysiological functions.Diagnostic efficacy of long non-coding RNA MALAT-1 in human cancers: a meta-analysis study.

P2860

Q26748862-31538C97-98F2-460F-B774-7B27A915B49A Q26753032-11D51F35-E349-44AC-A7C3-B312C7989E10 Q26753834-C703B795-3D44-4D3A-9C6A-87C8290493D5 Q26774456-6AD99A7B-1662-44B5-875C-23A847C21C4B Q28071872-80B16BBE-6B2D-4F7D-A4FE-B29477B4F7C0 Q33786847-0B7EA358-5EA5-4587-AE85-6608D32B943A Q33801182-A9A3D6AA-1089-4270-AF5B-48BA09398C8A Q35814012-ED811010-455B-41DE-995C-D91619BE110A Q36237774-7055DB5C-61BA-4954-87FC-2A7268E50A45 Q36260364-F92AA01A-31AA-4DAB-9784-015AC51F42E7 Q36331304-F8FF4F93-9730-4C4C-BB53-5AF9132E31AD Q36545476-97AA3C10-6D77-4002-B361-C6D7C5A49677 Q36562102-AC735A7F-08D2-48F6-A786-AC91D3520A0F Q36562263-343618CD-8C64-4DF8-B8CE-B9C4738C44BC Q37437329-E73FB587-3F2D-4D50-BB83-3CB328C53B54 Q37724539-B3EA66BB-FAD2-4C55-8F57-057AFF68113F Q38531097-3EC951B4-F34C-4654-8032-F7C80510DBE3 Q38616693-6034F4EB-F658-4FA4-83C3-775E5AC3E151 Q38698171-F2454E62-2E79-4162-9223-BF44E6BE8DA9 Q38744451-454C23C1-AA99-4F16-8BEE-C8A33BB90F79 Q38878172-A708A0AD-D0E4-4A6A-8C46-0E008A78F835 Q38957351-4CD75C6E-CADB-4D15-9082-B93A05FA805A Q38979885-18FB5103-9E94-44CC-9993-AEC06056065D Q39031286-90BA36E2-8382-42FC-B2B0-C9DF29BAC7C3 Q39152842-37FE5FEF-F6BF-4169-A23A-E0548F75D118 Q39243268-222964AA-99A4-46F1-A2F7-DACDA868C700 Q39328241-AC43FEBD-0252-4432-AEAA-72E31CF7FE5F Q39368869-8098905C-1D9F-41DB-BD0F-2B7114B3D58F Q40292335-8481BC87-E4ED-4C39-9E0E-B9AE8C0CEB1C Q40293958-58212572-C919-4005-8C83-B2E2A962009D Q40700592-5958150B-6697-4C71-ACAF-0064F0E955A7 Q40942965-F1D29440-4559-41EC-B9DF-29A91627BBB9 Q40967746-E73BF544-7006-431A-ABAF-2D316C5FFB76 Q41553095-CC21FA79-DAB2-40FA-B501-14F3D8D14ACB Q41679740-473A76CB-1A8F-44C6-AC54-569C7B1DE670 Q42353504-FC0C433B-0D26-414A-B46C-0E6D971E5E2D Q42687941-899C8A55-86E6-4CC7-A4C1-A1678B4F2CC2 Q43061701-D224AFFF-A956-498D-BC5A-B1087FC3B5D1 Q46316816-EE4F3F4E-64F8-404D-B703-3337445D8299 Q47137423-4FEE86F3-38A3-4D6E-B530-C141623D936F

P2860

Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer.

http://www.wikidata.org/entity/Q34957004

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Development and prospective mu ...... biomarker for prostate cancer.

@ast

Development and prospective mu ...... biomarker for prostate cancer.

@en

Development and prospective mu ...... biomarker for prostate cancer.

@nl

type

label

Development and prospective mu ...... biomarker for prostate cancer.

@ast

Development and prospective mu ...... biomarker for prostate cancer.

@en

Development and prospective mu ...... biomarker for prostate cancer.

@nl

prefLabel

Development and prospective mu ...... biomarker for prostate cancer.

@ast

Development and prospective mu ...... biomarker for prostate cancer.

@en

Development and prospective mu ...... biomarker for prostate cancer.

@nl

P1433

Q34957004-AC30BB05-B267-47A5-8AB3-A056460559CE

P1476

Q34957004-96357C4D-33E2-4F86-B42D-466CE8E88175

P2093

Q34957004-107F3B15-CCFF-4B96-8E40-C2A57C12540F

Q34957004-124B1F23-C991-47D1-8631-9D3D2CB3E31D

Q34957004-28F6CBED-4568-46A8-B8E7-7AFEE1B9C26E

Q34957004-3986EA02-D9A7-4AB7-8278-705A94060AAB

Q34957004-3B461693-B66D-4129-9472-A2602F13174D

Q34957004-5CEF4C57-B9F6-4254-AC07-826DE43CE50C

Q34957004-689FA66C-7CFC-4BDD-8DB5-F51BD7FBD833

Q34957004-6CD1041E-456A-4792-8A75-EEAADBB1988F

Q34957004-70A81963-12E7-41BB-8A7F-440543FDA414

Q34957004-8594D502-8093-45B9-B64A-4EC2620338A5

P2860

Q34957004-006D9426-74C4-43BA-8BCF-BB39A22BF86A

Q34957004-04FA0C52-2639-4440-A64F-409FE3288EFD

Q34957004-06E4A3B1-AE09-4E85-960B-2B4F71FF0632

Q34957004-0B87A380-B497-41E6-83CB-8536C5DBA31E

Q34957004-11237B57-E61C-4D44-951B-F4BA20A52DFA

Q34957004-13476E17-6D36-4A50-AE4B-0AC1C7B28CBD

Q34957004-1A90E74A-90B6-422D-AA5A-4BAE35A3F6E7

Q34957004-223731C4-CD14-4837-B18A-5D073B9439B9

Q34957004-2BAFA765-09A3-4EF9-B5D8-7F33E65C8C34

Q34957004-2EA654EF-3B10-4894-87F1-8807B90ADB87

P304

Q34957004-2162A0EB-97AA-43DA-9DF1-332B11337977

P31

Q34957004-4030B641-75F3-4CB6-9BE9-0B37EFB99104

P356

Q34957004-C8AFAEEB-6701-4778-AAAD-A1E584410D39

P407

Q34957004-F87118C1-EE30-4CD1-B62E-AEA62A8BA75C

P433

Q34957004-6ECE439E-720F-4D5E-AD1F-B23A8A6A4E03

P478

Q34957004-191779D4-A143-462B-9652-F7BC4E1CEF9D

P50

Q34957004-61D6E664-6D87-4907-A7C3-44EBAC3F44C2

P577

Q34957004-B4DD32DC-1F42-4E9F-92BF-FEBB0BFE4A97

P5875

Q34957004-8CBF7B24-F128-40E8-96DF-0BA4F8A15ABA

P698

Q34957004-707DA4AC-9B9E-4F75-8450-0825C2AFC33B

P921

Q34957004-05904007-B5DD-4595-AF15-27F1BCF5C62F

Q34957004-40339B8A-844F-43F1-9F96-19C345EF8AD2

P932

Q34957004-B8E89B3C-FC9F-428E-837F-C03FE8B6A1A1

P356

ONCOTARGET.2691

P1433

P1476

Development and prospective mu ...... biomarker for prostate cancer.

@en

P2093

Bin Liu

http://www.w3.org/2001/XMLSchema#string

Chao Zhang

http://www.w3.org/2001/XMLSchema#string

Chengyao Wu

http://www.w3.org/2001/XMLSchema#string

Chuanliang Xu

http://www.w3.org/2001/XMLSchema#string

Dan Shen

http://www.w3.org/2001/XMLSchema#string

Danfeng Xu

http://www.w3.org/2001/XMLSchema#string

Fei Guo

http://www.w3.org/2001/XMLSchema#string

Fubo Wang

http://www.w3.org/2001/XMLSchema#string

Haifeng Wang

http://www.w3.org/2001/XMLSchema#string

Huiqing Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer

Mortality results from a randomized prostate-cancer screening trial

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

Cancer statistics, 2013

Impact of glutathione-S-transferases (GST) polymorphisms and hypermethylation of relevant genes on risk of prostate cancer biochemical recurrence: a meta-analysis

Screening and prostate-cancer mortality in a randomized European study

MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer

DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.

MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes.

P304

11091-11102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.2691

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269767380

http://www.w3.org/2001/XMLSchema#string

P698

25526029

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

4294360

http://www.w3.org/2001/XMLSchema#string